The company is located in Boca Raton, Florida. For more information about Nabi Biopharmaceuticals, please visit our website at.. Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop and market products serious illnesses serious diseases. The company currently has three products on the market today: PhosLo , Nabi-HB [ Hepatitis B Immune Globulin ], and Aloprim for Injection. Nabi Biopharmaceuticals is focused on developing products that address unmet medical needs and offer commercial opportunities in our core business areas: Gram – positive bacterial infections, hepatitis, kidney disease , and nicotine addiction.
Progress and Next Steps – Nabi Biopharmaceuticals four Phase I / II trials have been completed, a total of nearly 200 patients, for NicVAX. These studies demonstrated that NicVAX is well tolerated, highly immunogenic, produced dose-dependent increase in antibody titers and showed a good indication of efficacy at 200 ug dose with a 33 to 40 % quit exchange rate administered over nine % for smokers with a placebo.Genetic factors are on CS have been identified. Specifically faults in some DNA repair factors as the CSB protein did premature aging premature aging, but the reasons are still unclear. For example, Cockayne syndrome commonly linked recessive mutations in COD gene, but the loss of all CSB in a subject in an individual typically. It implies that CS not just a deficiency in of functional CSB protein is shows that it continued expression continued expression of fragments COD or other protein in conjunction with the signal path.